Beta-lactamase variants
US10988749B2 · kind B2 · utility
1Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 22, 2017 |
| Grant date | Apr 27, 2021 |
| Priority date | — |
| Expiry date | May 16, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y305/02006
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an isolated polypeptide having beta-lactamase activity and nucleic acid sequences encoding the polypeptide. The isolated polypeptide of the invention is a VIM-2 variant with improved properties such as improved protease stability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.